| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.56B | $1.85B | $1.66B |
| YoY Revenue Growth % | -15.6% | +11.1% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$64.3M | $203.1M | $145.4M |
| Operating Margin % | -4.1% | 11.0% | 8.8% |
| Net Income (GAAP) | -$99.9M | $129.9M | $92.9M |
| EBITDA (Normalized) | $115.0M | $404.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $183.0M | $112.4M | $210.2M |
| Capital Expenditures (CapEx) | $224.2M | $251.6M | — |
| Free Cash Flow (FCF) | -$41.1M | -$139.2M | $210.2M |
| FCF Margin % | -2.6% | -7.5% | 12.6% |
| Return on Invested Capital (ROIC %) | -4.2% | 12.4% | — |
| Cash & Short-Term Equivalents | $26.8M | $19.4M | — |
| Total Debt (Short + Long Term) | $682.7M | $670.3M | — |
| Total Stockholders' Equity | $540.4M | $647.0M | — |